The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Atazanavir, sold under the trade name Reyataz among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure. It is taken by mouth once a day.
The global Atazanavir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Atazanavir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Atazanavir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Atazanavir include Bristol-Myers Squibb, TEVA, Cipla, Mylan, Aurobindo Pharma and Emcure, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Atazanavir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atazanavir.
Report Scope
The Atazanavir market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Atazanavir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atazanavir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
TEVA
Cipla
Mylan
Aurobindo Pharma
Emcure
Segment by Type
150 mg Capsule
200 mg Capsule
300 mg Capsule
50 mg Oral Powder
Segment by Application
Adults
Children 3 months of age and older
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Atazanavir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Atazanavir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Atazanavir, sold under the trade name Reyataz among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure. It is taken by mouth once a day.
The global Atazanavir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Atazanavir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Atazanavir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Atazanavir include Bristol-Myers Squibb, TEVA, Cipla, Mylan, Aurobindo Pharma and Emcure, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Atazanavir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atazanavir.
Report Scope
The Atazanavir market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Atazanavir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atazanavir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
TEVA
Cipla
Mylan
Aurobindo Pharma
Emcure
Segment by Type
150 mg Capsule
200 mg Capsule
300 mg Capsule
50 mg Oral Powder
Segment by Application
Adults
Children 3 months of age and older
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Atazanavir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Atazanavir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Atazanavir Market Overview
1.1 Product Overview and Scope of Atazanavir
1.2 Atazanavir Segment by Type
1.2.1 Global Atazanavir Market Value Comparison by Type (2024-2030)
1.2.2 150 mg Capsule
1.2.3 200 mg Capsule
1.2.4 300 mg Capsule
1.2.5 50 mg Oral Powder
1.3 Atazanavir Segment by Application
1.3.1 Global Atazanavir Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Children 3 months of age and older
1.4 Global Atazanavir Market Size Estimates and Forecasts
1.4.1 Global Atazanavir Revenue 2019-2030
1.4.2 Global Atazanavir Sales 2019-2030
1.4.3 Global Atazanavir Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Atazanavir Market Competition by Manufacturers
2.1 Global Atazanavir Sales Market Share by Manufacturers (2019-2024)
2.2 Global Atazanavir Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Atazanavir Average Price by Manufacturers (2019-2024)
2.4 Global Atazanavir Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Atazanavir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atazanavir, Product Type & Application
2.7 Atazanavir Market Competitive Situation and Trends
2.7.1 Atazanavir Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Atazanavir Players Market Share by Revenue
2.7.3 Global Atazanavir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Atazanavir Retrospective Market Scenario by Region
3.1 Global Atazanavir Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Atazanavir Global Atazanavir Sales by Region: 2019-2030
3.2.1 Global Atazanavir Sales by Region: 2019-2024
3.2.2 Global Atazanavir Sales by Region: 2025-2030
3.3 Global Atazanavir Global Atazanavir Revenue by Region: 2019-2030
3.3.1 Global Atazanavir Revenue by Region: 2019-2024
3.3.2 Global Atazanavir Revenue by Region: 2025-2030
3.4 North America Atazanavir Market Facts & Figures by Country
3.4.1 North America Atazanavir Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Atazanavir Sales by Country (2019-2030)
3.4.3 North America Atazanavir Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Atazanavir Market Facts & Figures by Country
3.5.1 Europe Atazanavir Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Atazanavir Sales by Country (2019-2030)
3.5.3 Europe Atazanavir Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atazanavir Market Facts & Figures by Country
3.6.1 Asia Pacific Atazanavir Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Atazanavir Sales by Country (2019-2030)
3.6.3 Asia Pacific Atazanavir Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Atazanavir Market Facts & Figures by Country
3.7.1 Latin America Atazanavir Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Atazanavir Sales by Country (2019-2030)
3.7.3 Latin America Atazanavir Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Atazanavir Market Facts & Figures by Country
3.8.1 Middle East and Africa Atazanavir Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Atazanavir Sales by Country (2019-2030)
3.8.3 Middle East and Africa Atazanavir Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Atazanavir Sales by Type (2019-2030)
4.1.1 Global Atazanavir Sales by Type (2019-2024)
4.1.2 Global Atazanavir Sales by Type (2025-2030)
4.1.3 Global Atazanavir Sales Market Share by Type (2019-2030)
4.2 Global Atazanavir Revenue by Type (2019-2030)
4.2.1 Global Atazanavir Revenue by Type (2019-2024)
4.2.2 Global Atazanavir Revenue by Type (2025-2030)
4.2.3 Global Atazanavir Revenue Market Share by Type (2019-2030)
4.3 Global Atazanavir Price by Type (2019-2030)
5 Segment by Application
5.1 Global Atazanavir Sales by Application (2019-2030)
5.1.1 Global Atazanavir Sales by Application (2019-2024)
5.1.2 Global Atazanavir Sales by Application (2025-2030)
5.1.3 Global Atazanavir Sales Market Share by Application (2019-2030)
5.2 Global Atazanavir Revenue by Application (2019-2030)
5.2.1 Global Atazanavir Revenue by Application (2019-2024)
5.2.2 Global Atazanavir Revenue by Application (2025-2030)
5.2.3 Global Atazanavir Revenue Market Share by Application (2019-2030)
5.3 Global Atazanavir Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporation Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Atazanavir Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol-Myers Squibb Atazanavir Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 TEVA
6.2.1 TEVA Corporation Information
6.2.2 TEVA Description and Business Overview
6.2.3 TEVA Atazanavir Sales, Revenue and Gross Margin (2019-2024)
6.2.4 TEVA Atazanavir Product Portfolio
6.2.5 TEVA Recent Developments/Updates
6.3 Cipla
6.3.1 Cipla Corporation Information
6.3.2 Cipla Description and Business Overview
6.3.3 Cipla Atazanavir Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cipla Atazanavir Product Portfolio
6.3.5 Cipla Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Atazanavir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Atazanavir Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Corporation Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Atazanavir Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aurobindo Pharma Atazanavir Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 Emcure
6.6.1 Emcure Corporation Information
6.6.2 Emcure Description and Business Overview
6.6.3 Emcure Atazanavir Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Emcure Atazanavir Product Portfolio
6.6.5 Emcure Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atazanavir Industry Chain Analysis
7.2 Atazanavir Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atazanavir Production Mode & Process
7.4 Atazanavir Sales and Marketing
7.4.1 Atazanavir Sales Channels
7.4.2 Atazanavir Distributors
7.5 Atazanavir Customers
8 Atazanavir Market Dynamics
8.1 Atazanavir Industry Trends
8.2 Atazanavir Market Drivers
8.3 Atazanavir Market Challenges
8.4 Atazanavir Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
